|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
2
Trodelvy Misses Primary Endpoint in ASCENT-07 Breast Cancer Trial
3
Myeloma Advocate Stresses Support for Caregivers in Black Community
4
Top Lung Cancer Stories from October: Insights, and Patient Journeys
5
